Actavis Generics is a global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, generic and over- the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries. The company has global headquarters in ...
Jan 24, 2013 ... PARSIPPANY, N.J. , Jan. 24, 2013 /PRNewswire/ -- Watson Pharmaceuticals, Inc . today announced that the company has adopted Actavis, Inc. (NYSE: ACT) as its new global name and will today begin trading under a new symbol — ACT — on the New York Stock Exchange . The company first announced ...
Watson Pharmaceuticals, Inc. Watson Pharmaceuticals, Inc. is now part of Allergan plc (March 2015). See: Allergan plc. Latest Drug Information Updates. Steglatro Steglatro (ertugliflozin) is a sodium-glucose co-transporter-2 (SGLT2) inhibitor to help improve glycemic... Ozempic Ozempic (semaglutide) is a glucagon-like ...
Read about the history of Watson Pharmaceuticals Inc. Explore the company's history, profile, and timeline. Find the key facts you're looking for!
Jan 24, 2013 ... PARSIPPANY, N.J., Jan. 24, 2013 /PRNewswire/ -- Watson Pharmaceuticals, Inc. is Now Actavis, Inc. - Company Begins Trading as 'ACT' - - Multi-year...
At Teva Pharmaceutical Industries, we improve people's health through our products, integrated R&D, generic medicines and global businesses.
The lawsuit names Watson Laboratories, now a subsidiary of Teva; Allergan Finance LLC, also known as Watson Pharmaceuticals Inc.; Activis Inc.; and Allergan plc. The action claims that as a result of the agreement, consumers had to pay hundreds of millions of dollars in surpa-competitive prices for prescriptions of ...
Watson Pharmaceuticals headquartered in Corona, California, is a leading global specialty pharmaceutical company.
Save. May 2, 2012. Pharmaceuticals · Sandoz gains dermatology lead with Fougera. Novartis generics division in $1.5bn acquisition. Save. April 26, 2012. Lex · Watson / Actavis: a generic drug cocktail. The Actavis buy more than doubles its global presence but big deals cannot offset generic pharma's problems. Save.